Ahead of the next round of talks at the World Trade Organization (WTO) to discuss a proposal by South Africa and India to waive monopolies on COVID-19 medical tools during the pandemic, Médecins Sans Frontières/Doctors Without Borders (MSF) called on the wealthy countries opposing the proposal not...
As the US Food and Drug Administration (FDA) starts meeting today and later this month to discuss emergency use authorisation of both the Pfizer/BioNTech and Moderna COVID-19 vaccine candidates, Médecins Sans Frontières/Doctors Without Borders (MSF) warns that any eventual COVID-19 vaccine approval...
Terms of a deal disclosed show that we cannot rely on pharma’s goodwill to do the right thing, even in a pandemic. After the worrying terms of a deal struck between pharmaceutical corporation AstraZeneca and Brazilian public research body Fundação Oswaldo Cruz (Fiocruz) were disclosed recently,...
The pharmaceutical corporation Johnson & Johnson (J&J) today announced a reduced price of US$1.50* per day for the tuberculosis (TB) drug bedaquiline, which is an important step that should allow more people with drug-resistant forms of TB (DR-TB) to access this lifesaving drug. But the...
We're in a time of unprecedented mobilisation to tackle COVID-19. Governments and philanthropies have contributed billions to the research and development of COVID-19 vaccines, while Gavi 1 , the Vaccine Alliance, has recently launched a new fund – the COVAX Facility 2 – to make advance purchases...
Governments must attach strings as they pledge billions to pay for vaccines in developing countries Doctors Without Borders/Médecins Sans Frontières (MSF) urged leaders to demand pharmaceutical corporations commit to selling any potential future COVID-19 vaccines at cost, as Gavi, the Vaccine...
Médecins Sans Frontières/Doctors Without Borders (MSF) welcomed today’s launch of the World Health Organization (WHO) Solidarity Call to Action for equitable global access to COVID-19 health technologies through sharing of knowledge, intellectual property and data. As an international medical...
MSF criticises pharma for dragging feet on developing HIV drugs for children 1 December, 2018 is the 30th anniversary of World AIDS Day, ahead of a Vatican City meeting on scaling up HIV diagnosis and treatment for children, the international medical humanitarian organisation Médecins Sans...
Unjust monopoly blocks access to treatment for millions of people with hepatitis C The Chinese Patent Re-examination Board (PRB) held a vital public hearing today on Médecins Sans Frontières’ (MSF) request to invalidate the patent granted to US pharmaceutical corporation Gilead Sciences for the...
